東(dong)瑞(rui)制(zhi)藥(yao)始創于(yu)1995年(nian)12月(yue)(yue),主要(yao)從事頭孢類抗(kang)生素以及(ji)系統(tong)專(zhuan)科藥(yao)物的開(kai)發、制(zhi)造及(ji)銷售(shou)。東(dong)瑞(rui)制(zhi)藥(yao)(控股)有限公司于(yu)2003年(nian)7月(yue)(yue)11日在香港聯交所主板上市,股份代號:2348。
東(dong)瑞(rui)(rui)(rui)(rui)製藥(控股(gu))有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)下轄東(dong)瑞(rui)(rui)(rui)(rui)國際有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)、東(dong)瑞(rui)(rui)(rui)(rui)國際股(gu)份有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)、東(dong)瑞(rui)(rui)(rui)(rui)生物投資發展(亞洲)有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)、蘇(su)(su)州東(dong)瑞(rui)(rui)(rui)(rui)製藥有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)、蘇(su)(su)州東(dong)瑞(rui)(rui)(rui)(rui)醫(yi)藥科(ke)技有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)、東(dong)瑞(rui)(rui)(rui)(rui)(南通)醫(yi)藥科(ke)技有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)、東(dong)瑞(rui)(rui)(rui)(rui)藥業(ye)(香港)有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)、福建東(dong)瑞(rui)(rui)(rui)(rui)制(zhi)藥有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)及(ji)蘭州東(dong)瑞(rui)(rui)(rui)(rui)制(zhi)藥有(you)(you)限(xian)公(gong)(gong)(gong)司(si)(si)(si)等九家子公(gong)(gong)(gong)司(si)(si)(si)。作為香港上市公(gong)(gong)(gong)司(si)(si)(si),本集團整體決(jue)策管理(li)嚴(yan)格(ge)恪守香港企業(ye)管治要(yao)求(qiu),業(ye)務(wu)定(ding)位(wei)面向全(quan)球,具(ju)備(bei)全(quan)球視角(jiao)和世(shi)界文化包容性,是(shi)投資者可信(xin)賴的企業(ye)。
東瑞(rui)制(zhi)(zhi)藥(yao)(yao)頭孢(bao)類抗(kang)生(sheng)素產(chan)(chan)品(pin)(pin)包(bao)括中間體(ti)、原料藥(yao)(yao)和(he)粉針劑;專科藥(yao)(yao)物覆蓋心血(xue)管系(xi)統(tong)、抗(kang)乙肝病毒、抗(kang)過(guo)敏、消(xiao)化系(xi)統(tong)、泌尿系(xi)統(tong)和(he)內(nei)分泌系(xi)統(tong),劑型有片劑、膠囊劑、顆粒劑。在頭孢(bao)類抗(kang)生(sheng)素生(sheng)產(chan)(chan)方面(mian),東瑞(rui)制(zhi)(zhi)藥(yao)(yao)形成了從藥(yao)(yao)物中間體(ti)、原料藥(yao)(yao)到制(zhi)(zhi)劑的綜(zong)合(he)性生(sheng)產(chan)(chan)特色,尤其(qi)在第三代頭孢(bao)菌素合(he)成方面(mian)擁有先進技術平(ping)臺,產(chan)(chan)品(pin)(pin)質量達到國(guo)際(ji)先進水(shui)平(ping),構建了品(pin)(pin)種系(xi)列齊全、綜(zong)合(he)配套功(gong)能完善、產(chan)(chan)能潛力大的頭孢(bao)產(chan)(chan)業(ye)鏈,是國(guo)內(nei)各大型藥(yao)(yao)品(pin)(pin)廠(chang)商和(he)眾多國(guo)外藥(yao)(yao)品(pin)(pin)廠(chang)商的原料供應(ying)商。
東(dong)瑞(rui)制藥(yao)(yao)(yao)研(yan)(yan)(yan)發(fa)(fa)中心成立于2002年,核心研(yan)(yan)(yan)發(fa)(fa)人(ren)(ren)員近50人(ren)(ren),是一(yi)支(zhi)以(yi)專(zhuan)(zhuan)業(ye)技(ji)術人(ren)(ren)員為(wei)骨干(gan),由博(bo)士、碩士等研(yan)(yan)(yan)究人(ren)(ren)員組(zu)成的(de)研(yan)(yan)(yan)發(fa)(fa)團隊。研(yan)(yan)(yan)發(fa)(fa)方向(xiang)主(zhu)要以(yi)系(xi)統專(zhuan)(zhuan)科(ke)藥(yao)(yao)(yao)物仿(fang)制藥(yao)(yao)(yao)為(wei)主(zhu),同(tong)時兼顧(gu)三類(lei)新(xin)藥(yao)(yao)(yao)的(de)研(yan)(yan)(yan)發(fa)(fa)和一(yi)些創新(xin)藥(yao)(yao)(yao)的(de)探索(suo),每年研(yan)(yan)(yan)發(fa)(fa)投入約占系(xi)統專(zhuan)(zhuan)科(ke)藥(yao)(yao)(yao)物銷售金額的(de)10%。目前,東(dong)瑞(rui)制藥(yao)(yao)(yao)已(yi)建立起“安(an)”系(xi)列心血管藥(yao)(yao)(yao)物品牌,而本(ben)集團的(de)專(zhuan)(zhuan)科(ke)藥(yao)(yao)(yao)物苯磺酸氨氯(lv)(lv)地(di)平(ping)片(安(an)內真®)、氯(lv)(lv)沙坦鉀氫氯(lv)(lv)噻嗪片(安(an)內喜(xi)®)、鹽酸西替(ti)(ti)利嗪片(西可韋(wei)(wei)®)、恩(en)替(ti)(ti)卡韋(wei)(wei)分散片(雷易得(de)®)皆為(wei)國內獲準(zhun)生(sheng)產上市(shi)的(de)產品,市(shi)場(chang)占有(you)率(lv)位居前列。
東(dong)瑞(rui)制(zhi)藥(yao)按不同的產品(pin)線(xian)組建4支銷售(shou)隊(dui)伍(wu),分別涵蓋(gai)醫院(yuan)、流通、原料及(ji)進出口幾種模式。現有銷售(shou)人(ren)員(yuan)550人(ren)左右,在全國擁(yong)有90多個辦(ban)事處,其(qi)中40%在一(yi)線(xian)城(cheng)(cheng)市,30%在二(er)線(xian)城(cheng)(cheng)市,因此東(dong)瑞(rui)制(zhi)藥(yao)具(ju)備將新產品(pin)迅速覆(fu)蓋(gai)到醫院(yuan)的良好能力。
東(dong)瑞制(zhi)(zhi)藥(yao)(yao)(yao)擁(yong)有(you)完善的(de)(de)質量管理(li)體系,現(xian)有(you)廠房嚴格(ge)按照歐盟標準建設。東(dong)瑞制(zhi)(zhi)藥(yao)(yao)(yao)將始終以致(zhi)力于人類(lei)的(de)(de)健(jian)康事業為(wei)己任(ren),憑借高度的(de)(de)社會責任(ren)感與前瞻性的(de)(de)思維,通過(guo)持續的(de)(de)技術創新(xin),不斷為(wei)社會提供安全有(you)效(xiao)的(de)(de)藥(yao)(yao)(yao)物(wu),成為(wei)世界先進的(de)(de)制(zhi)(zhi)藥(yao)(yao)(yao)企業,為(wei)人類(lei)的(de)(de)健(jian)康事業作極(ji)致(zhi)的(de)(de)貢獻(xian)。